Your browser doesn't support javascript.
loading
Oncolytic Virus-Mediated Targeting of PGE2 in the Tumor Alters the Immune Status and Sensitizes Established and Resistant Tumors to Immunotherapy.
Hou, Weizhou; Sampath, Padma; Rojas, Juan J; Thorne, Steve H.
Afiliação
  • Hou W; Department of Cell Biology, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA 15213, USA.
  • Sampath P; Department of Cell Biology, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA 15213, USA.
  • Rojas JJ; Department of Cell Biology, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA 15213, USA.
  • Thorne SH; Department of Cell Biology, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA 15213, USA; Department of Immunology, G17a, Hillman Cancer Center, University of Pittsburgh, 5117 Center Avenue, Pittsburgh, PA 15213, USA. Electronic address: thornesh@upmc.edu.
Cancer Cell ; 30(1): 108-119, 2016 07 11.
Article em En | MEDLINE | ID: mdl-27374223
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dinoprostona / Hidroxiprostaglandina Desidrogenases / Marcação de Genes / Quimiocinas / Terapia Viral Oncolítica / Neoplasias Experimentais Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dinoprostona / Hidroxiprostaglandina Desidrogenases / Marcação de Genes / Quimiocinas / Terapia Viral Oncolítica / Neoplasias Experimentais Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2016 Tipo de documento: Article